IGF1R and breast carcinoma: This study shows that the presence of IGF1R SNVs rs3743259 and rs3743258 is associated with worse pathological response compared to the reference genotype in this cohort of patients with breast cancer treated with neoadjuvant chemotherapy (see Table 3).